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Objective: No recent meta-analysis has examined the effects of cognitive-behavioural 
therapy (CBT) for adult depression. We decided to conduct such an updated meta-analysis.
Methods: Studies were identified through systematic searches in bibliographical 
databases (PubMed, PsycINFO, Embase, and the Cochrane library). We included studies 
examining the effects of CBT, compared with control groups, other psychotherapies, and 
pharmacotherapy.
Results: A total of 115 studies met inclusion criteria. The mean effect size (ES) of 94 
comparisons from 75 studies of CBT and control groups was Hedges g = 0.71 (95% CI 
0.62 to 0.79), which corresponds with a number needed to treat of 2.6. However, this may 
be an overestimation of the true ES as we found strong indications for publication bias 
(ES after adjustment for bias was g = 0.53), and because the ES of higher-quality studies 
was significantly lower (g = 0.53) than for lower-quality studies (g = 0.90). The difference 
between high- and low-quality studies remained significant after adjustment for other study 
characteristics in a multivariate meta-regression analysis. We did not find any indication that 
CBT was more or less effective than other psychotherapies or pharmacotherapy. Combined 
treatment was significantly more effective than pharmacotherapy alone (g = 0.49).
Conclusions: There is no doubt that CBT is an effective treatment for adult depression, 
although the effects may have been overestimated until now. CBT is also the most studied 
psychotherapy for depression, and thus has the greatest weight of evidence. However, 
other treatments approach its overall efficacy.
W W W
Une méta-analyse de la thérapie cognitivo-comportementale 
pour la dépression adulte, seule et en comparaison avec d’autres 
traitements 
Objectif : Aucune méta-analyse récente n’a examiné les effets de la thérapie cognitivo-
comportementale (TCC) sur la dépression adulte. Nous avons décidé de mener cette mise 
à jour de méta-analyses.
Méthodes : Des études ont été identifiées lors de recherches systématiques dans les 
bases de données bibliographiques (PubMed, PsycINFO, Embase, et Cochrane library). 
Nous avons inclus des études qui examinent les effets de la TCC, comparé à des groupes 
témoins, d’autres psychothérapies, et la pharmacothérapie.
Résultats : Un total de 115 études satisfaisaient aux critères d’inclusion. L’ampleur (AE) 
moyenne de l’effet de 94 comparaisons dans 75 études de TCC et de groupes témoins 
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Abbreviations
BA behavioural activation
BDI Beck Depression Inventory
CAU care as usual
CBT cognitive-behavioural therapy
CMA Comprehensive Meta-Analysis
CT cognitive therapy
ES effect size
HRSD Hamilton Rating Scale for Depression
IPT interpersonal psychotherapy
NNT number needed to treat
PST problem-solving therapy
RCT randomized controlled trial
Clinical Implications
• CBT is an effective treatment for adult depression.
• Although there is no evidence that CBT is more effective 
than other psychotherapies, it remains the best-studied 
type of therapy.
• Combined treatment of CBT and pharmacotherapy is 
significantly more effective than pharmacotherapy alone.
Limitations
• Heterogeneity was high in all analyses, indicating 
considerable differences between the ES of the different 
studies.
• Only short-term effects were examined.
• The quality of a considerable number of included studies 
was low.
Cognitive-behavioural therapy is the most researched form of psychotherapy for adult depression. However, 
meta-analytic reviews of the research on CBT for depression 
have varied in important manners in that some were focused 
closely on Beck’s approach to cognitive therapy,1 whereas 
others have employed a broader definition of the cognitive-
behavioural approach to depression.2 Further, although the 
number of comparative studies examining different types of 
psychotherapy has continued to increase,3 no recent meta-
analysis has focused specifically on CBT for depression.
Early meta-analyses all showed CBT to be more effective 
than no treatment for people with depression,4–8 although 
no firm evidence was found that CBT was any more or less 
efficacious than other psychotherapies or pharmacotherapy.
No recent meta-analysis has specifically focused on effect 
studies of CBT, and examined potential effect moderators 
and other sources of heterogeneity.
Therefore, our study provides an updated meta-analysis of 
CBT for the treatment of adult depression. We employed a 
broad definition of CBT,2 and compared CBT with control 
groups, pharmacotherapy, and other psychotherapies. One 
aim was to use the large number of available studies to 
compare CBT with wait-list, CAU, and placebo control 
groups. We also compared CBT with other psychotherapies, 
including nondirective supportive therapy, BA therapy, 
psychodynamic psychotherapy, IPT, PST, and other 
psychotherapies.
Method
Identification and Selection of Studies
We used a database of 1237 papers on the psychological 
treatment of depression. This database has been described by 
Cuijpers et al9 and has been used in a series of earlier meta-
analyses.10 The database is continuously updated and was 
developed through a comprehensive literature search (from 
1966 to January 2011) in which 12 368 abstracts in PubMed 
(3077 abstracts), PsycINFO (2860), Embase (3811), and the 
Cochrane Central Register of Controlled Trials (2885) were 
examined. These abstracts were identified by combining 
terms indicative of psychological treatment and depression 
(both MeSH terms and text words). For this database, the 
primary studies from 42 meta-analyses of psychological 
treatment for depression were also checked to ensure that no 
published studies had been missed.10 For our study, the full 
texts of these 1237 papers were examined. The reference 
lists of earlier reviews of CBT were also examined, as well 
as the references of the included primary studies.
était au g de Hedges de 0,71 (IC à 95 % 0,62 à 0,79), ce qui correspond au nombre 
nécessaire pour traiter, soit 2,6. Toutefois, ceci peut être une surestimation de la véritable 
AE car nous avons trouvé de fortes indications de biais de publication (l’AE après 
correction pour biais était g = 0,53), et parce que l’AE des études de qualité supérieure 
était significativement plus faible (g = 0,53) que celle des études de qualité inférieure 
(g = 0,90). La différence entre les études de qualité supérieure et inférieure demeurait 
significative après correction pour d’autres caractéristiques des études dans une analyse 
de régression multivariée. Nous n’avons trouvé aucune indication que la TCC soit plus ou 
moins efficace que d’autres psychothérapies ou que la pharmacothérapie. Le traitement 
combiné était significativement plus efficace que la pharmacothérapie seule (g = 0,49).
Conclusions : Il n’y a aucun doute que la TCC est un traitement efficace de la 
dépression adulte, bien que les effets aient pu en être surestimés jusqu’ici. La TCC est 
également la psychothérapie pour la dépression la plus étudiée, et elle a donc la plus 
grande évidence. Toutefois, d’autres traitements s’approchent de son efficacité globale.
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We included RCTs in which the effects of CBT were 
compared with the effects of a control group (wait-list, 
CAU, placebo, or other) or another type of treatment 
(psychotherapy or pharmacotherapy) in adults and where the 
authors declared that the primary clinical problem treated 
was depression, assessed either by diagnostic interview 
or self-report questionnaire. We also included studies that 
compared pharmacotherapy with the combination of CBT 
and pharmacotherapy.
CBT was defined as a therapy in which the therapist focuses 
on the impact that a patient’s present dysfunctional thoughts 
affect current behaviour and functioning.11 CBT helps clients 
to evaluate, challenge, and modify their dysfunctional beliefs 
(cognitive restructuring), in part to promote behavioural 
change and improve their functioning. Therapists use a 
psychoeducational approach, and teach patients new ways 
to cope with stressful situations; however, CBT therapists 
emphasize homework assignments and outside-of-session 
activities, through the method of collaborative empiricism, 
to directly experience the value of proposed changes within 
therapy sessions. We distinguished 2 main types of CBT: 
1. CBT in which cognitive restructuring is the core 
element of the treatment.
2. CBT in which cognitive restructuring is an important 
component, but in which at least 2 other components 
(such as BA, social skills training, relaxation, or 
coping skills) also have a prominent place. One 
example of this latter approach is the Coping with 
Depression course.12 
Within the first subtype, we distinguished 2 variants:
a. The manual developed by Beck et al1 is the most 
widely used manual for CBT (which includes a 
module on BA; see below).
b. In several studies, cognitive restructuring is used as a 
treatment (with or without a module on BA), but no 
explicit reference is made to Beck et al’s manual, or 
where major adaptations were made to this manual.13
Therapies that could be considered to be part of a broader 
family of CBT, such as PST, BA, or social skills training, 
were not considered to be CBT if they did not include a 
module specifically focused on cognitive restructuring.
We excluded studies on children and adolescents below 18 
years of age, studies on inpatients, and studies that included 
patients who were not depressed (for example, studies 
that also included participants who only met criteria for 
anxiety disorders in the sample). Comorbid general medical 
or psychiatric disorders were not used as an exclusion 
criterion. No language restrictions were applied.
Quality Assessment and Data Extraction
The validity of included studies was assessed with 4 
criteria of the risk of bias assessment tool, developed by the 
Cochrane Collaboration to assess possible sources of bias 
in RCTs14: 
1. Adequate generation of allocation sequence.
2. Concealment of allocation to conditions.
3. Prevention of knowledge of the allocated intervention 
to assessors of outcome. 
4. Dealing with incomplete outcome data.
Data extraction was conducted by 2 independent researchers.
We coded several aspects of the included studies, including 
participant characteristics (recruitment method, definition 
of depression, and target group), intervention characteristics 
(format, number of sessions, and type of psychotherapy 
with which CBT was compared), and study characteristics 
(type of control group, type of medication, and intention-
to-treat analyses).
Meta-Analyses
For each comparison between a CBT and a comparison 
group, the ES indicating the difference between the 2 groups 
at posttest was calculated (Cohen d or standardized mean 
difference). ESs were calculated by subtracting (at posttest) 
the average score of the CBT group from the average 
score of the comparison group, and dividing the result by 
the pooled standard deviations of the 2 groups. ESs of 0.8 
can be assumed to be large, while ESs of 0.5 are moderate, 
and ESs of 0.2 are small.15 Because several studies had 
small sample sizes, we adjusted for small sample bias as 
suggested by Hedges and Olkin (Hedges g).16
In the calculations of ESs, we only used instruments that 
explicitly measured symptoms of depression, such as the 
BDI-I or -II17,18 or the HRSD.19 If more than one depression 
measure was used, the mean of the ESs was calculated, thus 
each study provided only one effect. If means and standard 
deviations were not reported, we used the procedures of the 
CMA software, version 2.2.021 (Biostat, Englewood, NJ; 
2013) to calculate the ES using dichotomous outcomes. If 
the ES could not be calculated with CMA, the study was 
excluded.
Pooled mean ESs were calculated with CMA. As we 
expected considerable heterogeneity among the studies, we 
used the random effects model.
The standardized mean difference (Hedges g) is not easy 
to interpret from a clinical perspective. Therefore, we also 
transformed the standardized mean differences into the 
NNT, using the formulae provided by Kraemer and Kupfer.20 
The NNT indicates the number of patients that have to be 
treated to generate one additional positive outcome.21
As an indicator of heterogeneity, we calculated the 
I2-statistic, which gives heterogeneity in percentages. A 
value of 0% indicates no observed heterogeneity, and larger 
values show increasing heterogeneity, with 25% as low, 
50% as moderate, and 75% as high heterogeneity.22 We also 
calculated the Q-statistic, but only report whether this was 
significant or not.
Subgroup analyses were conducted according to the mixed 
effect model. In this model, studies within subgroups are 
pooled with the random effects model, while tests for 
significant differences between subgroups are conducted 
with the fixed effects model. For continuous variables, 
we used meta-regression analyses to test whether there 
was a significant relation between the continuous variable 
and the ES. Publication bias was tested by inspecting the 
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funnel plot on primary outcome measures and by the trim 
and fill procedure, which yields an estimate of the ES 
after the publication bias has been taken into account (as 
implemented in CMA, version 2.2.021). We also conducted 
Egger’s test of the intercept to quantify the bias captured by 
the funnel plot and test whether it was significant.
Results
Selection and Inclusion of Studies
Having examined a total of 12 368 abstracts (9634 
after removal of duplicates), we retrieved 1237 full-text 
papers for further consideration. We excluded 1122 of the 
retrieved papers. Figure 1 presents a flowchart describing 
the inclusion process and describes the reason why studies 
were excluded. This process resulted in a total of 115 
studies that met our inclusion criteria and were included in 
this meta-analysis.
Characteristics of Included Studies
An overview of the characteristics of the set of included 
studies is presented in Table 1. Selected characteristics 
of each of the 115 included studies are reported online in 
eAppendix 1, and the references are presented in eAppendix 
2. Most studies recruited patients from the community, and 
were aimed at adults with major depressive disorder as the 
primary presenting problem. CBT was delivered according 
to the manual from Beck et al1 in most studies, and almost 
two-thirds of the CBT interventions had between 8 and 16 
sessions. Most of the studies were conducted in the United 
States. The quality of the included studies was not optimal. 
Only 43 studies met at least 3 of the 4 quality criteria.
CBT, Compared With Control Condition
The effects of CBT were compared with a control group in 
75 studies, with 94 comparisons (Table 2). The mean ES 
was a g of 0.71 (95% CI 0.62 to 0.79), which corresponds 
with a NNT of 2.60. Heterogeneity was moderate (I2 = 
56.66%), and highly significant.
Fourteen studies were included in which 2 or more CBT 
treatments were compared with the same control group. This 
means that multiple comparisons from this study were not 
independent of each other, but their use in the same analyses 
may have resulted in an artificial reduction of heterogeneity 
and therefore affected the pooled ES. We examined these 
possible effects by conducting sensitivity analyses in which 
we included only 1 ES per study. First, we included only the 
comparison with the largest ES from that study and then we 
conducted another analysis in which we included only the 
smallest ES. The resulting ESs (Table 2) were comparable 
with the ones found in the overall analyses. Heterogeneity 
remained moderate to high and highly significant in these 
analyses.
Figure 1  Flowchart of inclusion of studies
Figure 1  Flowchart of inclusion of studies
12 368 f id tifi dT t l f id tifi d b,  re erences en e
by literature search:
- PubMed: 3,077
- PsycINFO: 2,860
- Embase: 3,811
- Cochrane: 2,885
o a  re r nces en e y
literature search: 12 368
PubMed: 3077
PsycINFO: 2860
Embase: 3811
Cochrane: 2885
After removal of duplicates:
9,634 abstracts
Abstracts fter removal of 
duplica es: 9634
1,237 publications retrievedPublications retriev d: 1237
Excluded after reading 
abstract: 8397
Total excluded: 1122
• Studies with adolescents: 68
• Duplicate publication: 279
• No random assignment: 53
• Not only depression: 143
• No psychotherapy: 142
• No control condition: 116
• Maintenance trial: 49
• ES cannot be calculated: 18
• No CBT: 108
• Other reason: 146
RCTs on CBT included: 115
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We also calculated the ESs based exclusively on the HRSD 
and found somewhat higher results (g = 0.90; 95% CI 0.71 
to 1.08; I2 = 68.82; NNT= 2.10). The ES exclusively based 
on the BDI was comparable with the overall ES (g = 0.79; 
95% CI 0.66 to 0.92; I2 = 62.26; NNT = 2.36), as was the 
ES based on the BDI-II (g = 0.72; 95% CI 0.42 to 1.01; 
I2 = 73.41; NNT = 2.56).
Inspection of the funnel plot and the Duval–Tweedie trim 
and fill procedure indicated considerable publication bias. 
After adjustment for missing studies (n = 27), the ES 
dropped from a g of 0.71 to a g of 0.53 (95% CI 0.43 to 
0.62). The Egger test also pointed at an asymmetric funnel 
plot (intercept 1.61; 95% CI 1.11 to 2.10; P < 0.001).
We conducted a series of univariate subgroup analyses to 
examine the association between the ES and characteristics 
of the studies (Table 2). In these analyses, we found 
indications that CBT according to Beck’s procedures was 
significantly more effective than other CBT treatments, 
that recruitment from community samples resulted in a 
higher ES, that the ESs differed across the various target 
groups, that type of control group was significantly 
associated with the ES, that high-quality studies had lower 
ESs than low-quality studies, and that the ESs differed 
across various countries. We found no indication that ESs 
differed according to definition of depression (diagnostic 
interview, compared with self-report), and according to 
treatment format (individual, group, and guided self-
help). Heterogeneity was moderate and significant in most 
subgroups.
To further explore differences between subgroups of 
studies, we also conducted a multivariate meta-regression 
analysis (Table 3). We found that the ES was smaller in 
clinical samples, in adults, compared with more specific 
target groups, in high-quality studies, in studies conducted 
in the United States, compared with other countries, and 
in placebo and (or) other control groups. In contrast to 
the univariate analyses, we found no indication that CBT 
according to Beck’s procedures was significantly more 
effective than other CBT treatments.
Because we found that the quality of the study was 
significantly associated with the ES, both in the univariate 
and the multivariate meta-regression analysis, we conducted 
an additional univariate meta-regression analysis with 
the number of quality criteria that were met in the study 
as predictor. The resulting slope was –0.14 (95% CI –0.18 
to –0.10; P < 0.001), indicating that the average ES was 
lowered by 0.14, with each of the 4 quality criterion that 
was not met.
Pharmacotherapy, Compared With the Combination 
of Pharmacotherapy and CBT
We were able compare the effects of CBT plus 
pharmacotherapy with pharmacotherapy alone in 11 studies 
(Table 4). The mean ES was a g of 0.49 (95% CI 0.29 to 
0.69), with low and nonsignificant heterogeneity (I2 = 
16.48). The corresponding NNT was 3.68. ESs resulting 
from the HRSD and the BDI were comparable.
Table 1  Selected characteristics of studies of CBT 
for adult depression (n = 115)
Characteristic n %
Recruitment
Community 63 54.8
Clinical samples 28 24.3
Other methods 24 20.9
Diagnosis
Major depressive disorder 50 43.5
Diagnosed mood disorder 29 25.2
Self-report and (or) other 36 31.3
Target group
Adults in general 64 55.7
Older adults 15 13.0
Student populations 6 5.2
Women with PPD 8 7.0
General medical patients 13 11.3
Other 9 7.8
CBT type
Beck 41 35.7
Other cognitive restructuring 34 29.6
Other form of CBT 40 34.8
Number of sessions
<8 20 17.4
8–16 75 65.2
>16 20 17.4
Control group
Wait-list 37 32.2
CAU 26 22.6
Other control group 14 12.2
No controlled study 38 33.0
Country
United States 55 47.8
United Kingdom 16 13.9
Europe 17 14.8
Canada 10 8.7
Australia 6 5.2
Other 11 9.6
Quality
Sequence generation 44 38.3
Allocation concealment 41 35.7
Blinding of assessors 89 77.4
Intention-to-treat analyses 63 54.8
≥3 criteria 43 37.4
Comparisons
CBT, compared with control 75 65.2
PHA, compared with CBT + PHA 11 9.6
CBT, compared with PHA 20 17.4
CBT, compared with other therapies 46 40.0
PHA = pharmacotherapy; PPD = postpartum depression
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Table 2  Effects of CBT, compared with control conditions, at posttesta
Variable ncomp g 95% CI z I
2b NNT Pc
CBT, compared with control
All comparisons 94 0.71 0.62 to 0.79 16.10d 56.66d 2.60
One ES per study (only highest) 75 0.70 0.61 to 0.80 14.37d 61.82d 2.63
One ES per study (only lowest) 75 0.64 0.55 to 0.74 13.97d 57.40d 2.86
Only HRSD 32 0.90 0.71 to 1.08 9.47d 68.82d 2.10
Only BDI 57 0.79 0.66 to 0.92 11.63d 62.26d 2.36
Only BDI-II 13 0.72 0.42 to 1.01 4.78d 73.41d 2.56
13 outliers excludede 81 0.71 0.64 to 0.79 19.19f 22.18f 2.60
After adjustment for publication bias 94 0.53 0.43 to 0.62 3.42
Subgroup analysesg
CBT type Beck 21 0.92 0.71 to 1.14 8.29d 57.37h 2.07 0.04
Other cognitive restructuring 28 0.73 0.59 to 0.88 10.02d 50.67h 2.54
Other CBT 45 0.61 0.49 to 0.73 10.00d 55.57d 2.99
Recruitment Community 58 0.81 0.69 to 0.93 13.56d 50.47d 2.30 0.008
Clinical samples 17 0.51 0.36 to 0.67 6.63d 32.21 ns 3.55
Other 19 0.62 0.43 to 0.80 6.66d 70.93d 2.96
Diagnosis Formal diagnosis 56 0.70 0.59 to 0.82 12.13d 61.60d 2.63 0.91
Self-report 38 0.71 0.58 to 0.84 10.49d 48.11h 2.60
Target group Adults 52 0.70 0.59 to 0.81 12.03d 50.65d 2.63 0.02
Older adults 11 0.54 0.32 to 0.76 4.86d 54.46f 3.36
Student population 7 1.23 0.78 to 1.68 5.34d 51.53 ns 1.62
Women with PPD 7 0.59 0.47 to 0.71 9.71d 0 ns 3.09
General medical 9 0.88 0.67 to 1.10 8.07d 16.63 ns 2.15
Other 8 0.71 0.29 to 1.14 3.28h 80.98d 2.60
Format Individual 46 0.71 0.57 to 0.86 9.60d 61.87d 2.60 0.80
Group 27 0.71 0.58 to 0.83 10.73d 46.98h 2.60
Guided self-help 20 0.77 0.62 to 0.92 9.92d 31.30 ns 2.42
Control group Wait-list 55 0.83 0.72 to 0.94 15.17d 36.68h 2.26 0.003
CAU 26 0.59 0.42 to 0.76 6.93d 66.46d 3.09
Placebo and (or) other 13 0.51 0.32 to 0.69 5.48d 53.22f 3.55
Quality High (≥3 criteria) 39 0.53 0.43 to 0.63 10.66d 55.60d 3.42 <0.001
Low (≤2 criteria) 55 0.90 0.77 to 1.03 13.48d 93.20h 2.10
Country United States 43 0.90 0.74 to 1.05 11.25d 52.57d 2.10 <0.001
United Kingdom 14 0.41 0.26 to 0.57 5.25d 32.10 ns 4.39
European Union 14 0.52 0.37 to 0.66 7.07d 38.48 ns 3.50
Canada 4 0.99 0.29 to 1.68 2.79h 55.69 ns 1.94
Australia 8 0.67 0.32 to 1.01 3.80d 69.05h 2.75
Other 11 0.78 0.59 to 0.97 7.98d 53.33f 2.39
a All results are reported with Hedges g, according to the random effects model. 
b The P levels in this column indicate whether the Q-statistic is significant (the I2 statistic does not include a test of significance). 
c The P levels in this column indicate whether the difference between the ESs in the subgroups is significant. 
d P < 0.001 
e Outliers were defined as studies in which the 95% CI was outside the 95% CI of the pooled studies. (Below the 95% CI, see online 
eAppendix 1: Baker, 2010; Dowrick, 2000; Elkin 1989; Lamers, 2010; Miranda, 2003; Serfaty, 2009; Smit, 2006; Spek, 2007. Above the 
95% CI, see online eAppendix 1: Faramarzi, 2008; Jamison, 1995; Pecheur, 1984; Rohan, 2007; Taylor, 2009.) 
f P < 0.05 
g Subgroup analyses were conducted according to the mixed effects model. 
h P < 0.01  
ncomp = number of comparisons; ns = not statistically significant (P > 0.05); PPD = postpartum depression
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Because of the small number of comparisons, we conducted 
only a limited number of subgroup analyses (subgroups 
with less than 3 comparisons). There was no indication that 
the ES was associated with type of CBT, the quality of the 
study, or the type of medication (Table 4).
CBT, Compared With Pharmacotherapy
CBT was compared with pharmacotherapy in 20 studies 
(Table 4). The resulting ES was a g of 0.03 (95% CI 
–0.13 to 0.18, P > 0.05), indicating no significant overall 
difference in outcome between these 2 types of treatment. 
Heterogeneity was moderate but significant (I2 = 54.56, 
P < 0.01). The NNT was 62.50. Comparable ESs were found 
when limited to the HRSD and the BDI. Subgroup analyses 
(with more than 3 comparisons in each subgroup) did not 
point at any significant difference, and heterogeneity was 
moderate in most subgroups.
CBT, Compared With Other Psychotherapies
CBT could be compared directly with other psychotherapies 
in 46 studies (Table 4). ESs ranged from –0.02 to 0.25, and 
provided little indication that CBT was significantly more 
effective than nondirective supportive therapy, BA therapy, 
psychodynamic psychotherapy, IPT, PST, and other 
psychotherapies. The only ES that approached a moderate 
effect was the specific comparison between CBT and 
psychodynamic psychotherapy, but that result was based on 
only 5 studies, and with a broad confidence interval (–0.07 
to 0.58).
When we selected only the studies in which Beck’s manual 
was specifically used, we also found little indication that 
CBT was more effective than other psychotherapies (Table 
4). However, there were 2 comparisons, between CBT and 
supportive therapy (g = 0.26), and CBT and psychodynamic 
psychotherapy (g = 0.27), that clearly warrant further 
examination, as the number of studies was small and the 
pattern of results suggests a possible superiority of CBT 
with more research.
Discussion
Based on a large number of comparisons of CBT with a 
control or alternate intervention group, tour meta-analysis 
found that CBT is an efficacious treatment for adult 
depression.5,6,23,24 The comparison of CBT and control 
conditions yielded a large ES in favour of CBT (g = 0.71). 
However, this ES is an overestimation of the true ES, 
because we also found clear indications for publication bias. 
Further, the inclusion of a considerable number of lower-
quality studies has probably also led to an overestimation 
of the mean ES.
Our meta-analysis was the first to provide separate 
comparisons of CBT with wait-list, CAU, and placebo 
and (or) other control groups. These comparisons showed 
superiority of CBT to all control groups. However, the ES 
was significantly smaller in studies that compared CBT with 
placebo and (or) other control groups relative to studies 
that compared CBT with wait-list or CAU control groups, 
which is in line with earlier research.25
Subgroup analyses also showed differences in ESs across 
various countries. In particular, studies conducted in the 
United States produced larger ESs than studies conducted 
elsewhere. Within the current CBT and control group 
comparisons, ESs were also smaller for studies that used 
clinical samples, and for adults, compared with more 
specific target groups, including, for example, older adults, 
women with postpartum depression, and patients with 
general medical conditions. However, other evidence 
suggests that psychotherapy for depression is equally 
Table 3  Standardized regression coefficients of characteristics of studies on CBT in relation to the ES: 
multivariate meta-regression analyses
Variable b SE P
CBT type Beck
Other cognitive restructuring –0.49 0.13
Other CBT –0.18 0.13
Recruitment Clinical samples, compared with other –0.23 0.10 <0.05
Diagnosis Formal diagnosis, compared with self-report 0.17 0.10
Target group Adults, compared with specific group –0.17 0.08 <0.05
Number of sessions Continuous 0.00 0.01
Format Individual
Group 0.09 0.09
Guided self-help 0.20 0.14
Quality High, compared with low –0.21 0.09 <0.05
Control group Wait-list
CAU –0.10 0.11
Placebo and (or) other –0.27 0.11 <0.05
Country United States, compared with other 0.21 0.09 <0.05
Constant 0.89 0.19 <0.001
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Table 4  Effects of CBT at posttest, compared with pharmacotherapy alone or in combination, CBT, compared 
with pharmacotherapy, and CBT, compared with other psychotherapies, for adult depressiona
Variable ncomp g 95% CI z I
2b NNT Pc
Pharmacotherapy, compared with combined
All comparisons 11 0.49 0.29 to 0.69 4.75d 16.48 ns 3.68
BDI only 7 0.47 0.22 to 0.73 3.63d 26.36 ns 3.85
HRSD only 7 0.34 0.07 to 0.61 2.46e 35.16 ns 5.26
Subgroup analyses
CBT type Beck 5 0.47 0.17 to 0.78 3.04f 8.21 ns 3.85 0.91
Other 6 0.50 0.20 to 0.79 3.29f 33.96 ns 3.62
Quality High (≥3 criteria) 4 0.34 –0.11 to 0.79 1.49 ns 30.92 ns 5.26 0.42
Low (≤2 criteria) 7 0.55 0.33 to 0.77 4.94d 5.95 ns 3.31
Medication TCA 6 0.46 0.22 to 0.69 3.83d 0 ns 3.91 0.84
SSRI 3 0.45 –0.06 to 0.96 1.74 ns 54.50 ns 4
Other 2 0.89  –0.50 to 2.28 1.25 ns 64.61 ns 2.13
CBT, compared with pharmacotherapy
All studies 20 0.03 –0.13 to 0.18 0.33 ns 54.56f 62.5
2 outliers excluded 18 –0.05 –0.17 to 0.07 –0.81 ns 23.70 ns 35.71
BDI only 12 0.13 –0.13 to 0.38 0.96 ns 68.08d 13.51
HRSD only 15 0.06 –0.10 to 0.21 0.74 ns 42.98e 29.41
Subgroup analyses
CBT type Beck 13 0 –0.15 to 0.15 –0.03 ns 20.49 ns ∞ 0.70
Other 7 0.07 –0.25 to 0.39 0.40 ns 77.49d 25
Recruitment Community 7 –0.08 –0.25 to 0.09 –0.92 ns 0 ns 21.74 0.49
Clinical samples 9 0.04 –0.18 to 0.26 0.36 ns 47.80 ns 45.45
Other 4 0.21 –0.35 to 0.76 0.74 ns 83.51d 8.47
Target group Adults 16 –0.06 –0.19 to 0.08 –0.82 ns 25.19 ns 29.41 0.14
Other 4 0.32 –0.16 to 0.80 1.30 ns 82.62f 5.56
Quality High (≥3 criteria) 7 –0.11 –0.26 to 0.04 –1.44 ns 0 ns 16.13 0.14
Low (≤2 criteria) 13 0.1 –0.13 to 0.32 0.84 ns 63.47f 17.86
Medication TCA 7 0.15 –0.11 to 0.40 1.11 ns 42.73 ns 11.9 0.15
SSRI 7 0.05 –0.27 to 0.37 0.31 ns 73.43f 35.71
Other 6 –0.14 –0.31 to 0.03 –1.65 ns 0 ns 12.82
Country United States 12 0.02 –0.16 to 0.20 0.21 ns 48.63e 83.33 0.93
Other 8 0.04 –0.25 to 0.32 0.25 ns 65.66f 45.45
CBT, compared with other psychotherapies
Supportive therapy 16 0.1 –0.06 to 0.25 1.22 ns 26.75 ns 17.86
BA 8 –0.02 –0.25 to 0.21 –0.17 ns 0 ns 83.33
Psychodynamic psychotherapy 5 0.25 –0.07 to 0.58 1.52 ns 16.39 ns 7.14
IPT 5 –0.09 –0.39 to 0.20 –0.61 ns 41.53 ns 20
PST 3 –0.13 –0.39 to 0.13 –0.99 ns 0 ns 13.51
Other psychotherapies 9 –0.09 –0.29 to 0.12 –0.85 ns 0 ns 20
continued
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effective in younger and older adults.5,26 We have to 
remember with these subgroup analyses that they are only 
correlational associations and do not provide evidence 
for a causal relation. For example, it is very well possible 
that US studies used different methodologies than studies 
in other countries, and that these methodologies cause the 
difference in ESs.
Our current meta-analysis found that the combination 
of CBT and pharmacotherapy was superior to 
pharmacotherapy alone for the treatment of depression.27 
However, our meta-analysis found no difference in efficacy 
between CBT and pharmacotherapy in direct comparisons, 
which is inconsistent with early meta-analyses that found a 
superiority of CBT over antidepressants.5,6 Further, Butler 
et al23 pointed out that some of the early trials that compared 
CBT and medication had methodological characteristics 
that favoured CBT, and that earlier meta-analyses may 
have, therefore, overestimated the efficacy of CBT relative 
to pharmacotherapy. CBT may also be more efficacious 
than pharmacotherapy for long-term but not short-term 
outcomes, whereas our meta-analysis focused only on short-
term outcomes. A meta-analysis of longer-term effects of 
CBT reported that people who received CBT for depression 
had lower relapse rates after 1- and 2-year follow-up 
intervals than people treated with pharmacotherapy.28,29 
This issue warrants further consideration, as the evidence 
base grows and further analyses become possible.
The number of studies included in our meta-analysis 
allowed comparisons of CBT with other psychotherapies, 
including nondirective supportive therapy, BA therapy, 
psychodynamic psychotherapy, IPT, PST, and other 
psychotherapies. These comparisons indicate that CBT was 
no more or less effective than these other psychotherapies. 
However, some of these comparisons were based on a very 
small number of studies. For example, there were only 3 
studies in which CBT was compared with PST. Despite the 
somewhat limited database, these results converge with the 
conclusion made by Cuijpers et al24 that differences in ESs 
between psychotherapies for the treatment of depression are 
small and unstable across meta-analyses.
As previous meta-analyses have focused on CT,1 the 
specific effects of CT trials, compared with more generic 
CBT trials for depression, were examined. There was 
no indication that CT was more effective than other 
CBT treatments within comparisons that involved CBT, 
compared with pharmacotherapy, and CBT, compared with 
other psychotherapies. Collectively, the current results 
indicate that specific CT1 is no more effective than other 
forms of CBT.
The current meta-analysis has several limitations and 
considerations. The methodological quality of many of 
the studies included in the meta-analysis was suboptimal. 
While 37% (43/115) of the studies met at least 3 of the 4 
quality criteria,13 more studies failed to meet these criteria. 
As higher-quality studies tended to generate lower ESs, 
the inclusion of lower-quality studies may have produced 
an inflated estimate of the efficacy of CBT for adult 
depression. Second, although the overall number of studies 
was relatively large, several of the subgroup contrasts were 
based on a small number of studies. The failure to find 
significant differences between subgroups of studies may 
have been due to low statistical power rather than a true 
equivalency across subgroups.
Our meta-analysis was limited to the examination of the 
short-term efficacy of CBT. It is important to determine 
the long-term efficacy of CBT, compared with control 
groups, pharmacotherapy, and other psychotherapies.28,30 
Unfortunately, follow-up data are difficult to interpret using 
meta-analysis, owing to variable follow-up intervals that 
confound ESs with duration of follow-up, and between-
study differences in how the follow-up phase data are 
handled. Thus, while simple comparisons of proportions 
of relapse in groups of people who received CT, compared 
with pharmacotherapy, have found an advantage of CT,6 
and some research has found that CBT reduces the risk 
of relapse of depression,28,31,32 evaluations of the long-
term efficacy and relapse prevention effects of CBT for 
Table 4  continued
Variable ncomp g 95% CI z I
2b NNT Pc
CBT (Beck), compared with other 
psychotherapies
Supportive therapy 3 0.26 –0.28 to 0.79 0.95 ns 48.91 ns 6.85
BA 6 –0.09 –0.32 to 0.16 –0.69 ns 0 20.00
Psychodynamic psychotherapy 2 0.27 –0.26 to 0.80 1.01 ns 0 6.58
IPT 4 –0.21 –0.46 to 0.04 –1.67 ns 0 8.47
Other psychotherapies 7 –0.15 –0.36 to 0.07 –1.36 ns 0 11.9
a Effects are reported with Hedges g, according to the random effects model.
b The P levels in this column indicate whether the Q-statistic is significant (the I2 statistic does not include a test of significance).
c The P levels in this column indicate whether the difference between the ESs in the subgroups is significant.
d P < 0.001; e P < 0.05; f P < 0.01 
ncomp = number of comparisons; ns = not statistically significant (P > 0.05); SSRI = selective serotonin reuptake inhibitor;  
TCA = tricyclic antidepressant
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depression are needed, particularly in comparison with 
other interventions.
Finally, although CBT was found in the current analysis to be 
generally efficacious for the treatment of adult depression, 
not all people will benefit from CBT, and some people 
may respond better to other interventions than CBT. A few 
potential moderator variables were identified in this meta-
analysis, including target group and clinical, compared 
with community, recruitment of participants. However, 
meta-analyses cannot determine which treatment may be 
the most appropriate for any given person with depression. 
Future research will need to continue to investigate which 
of the individual, treatment, and study characteristics may 
influence the efficacy of CBT for depression.
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